Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Markets:
Overview
News
Currencies
International
Treasuries

Ainos, Inc. - Common Stock (NQ:AIMD)

3.205 -0.095 (-2.86%)
Streaming Delayed Price Updated: 11:36 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Ainos, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of... 
Via Benzinga
Topics Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning! 
Via InvestorPlace
AIMD Stock Earnings: Ainos Reported Results for Q1 2023
Ainos just reported results for the first quarter of 2023. 
Via InvestorPlace
AIMD Stock Earnings: Ainos Reported Results for Q2 2023
Ainos just reported results for the second quarter of 2023. 
Via InvestorPlace
AIMD Stock Earnings: Ainos Reported Results for Q3 2023
Ainos just reported results for the third quarter of 2023. 
Via InvestorPlace
Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement
Via ACCESSWIRE
Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in... 
Via Benzinga
Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical
Via ACCESSWIRE
Ainos Reports Third Quarter 2023 Financial Results
Via ACCESSWIRE
Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement
Via ACCESSWIRE
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning! 
Via InvestorPlace
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan
Via ACCESSWIRE
Ainos Reports Second Quarter 2023 Financial Results
Via ACCESSWIRE
Ainos Celebrates First Listing Anniversary on Nasdaq
Via ACCESSWIRE
Ainos, Inc. Announces Stock Consolidation
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest movements happening this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. 
Via Benzinga
With Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV Patients
Boston, Massachusetts--(Newsfile Corp. - September 19, 2023) - The U.S. Food and Drug Administration (FDA) has granted Ainos' (NASDAQ:... 
Via Newsfile
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Ainos, Inc - The AI Nose "Knows" What's Inside Your Body and Beyond
Boston, Massachusetts--(Newsfile Corp. - August 15, 2023) - Here at Horizon Insights, we see... 
Via Newsfile
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.